Last update:

HIV & AIDS news

Medications

Gilead licenses HIV-prevention drug to generic drugmakers

US pharmaceutical giant Gilead said Wednesday it had signed licensing deals with six generic drugmakers to produce and sell its HIV prevention medicine in lower-income countries.

HIV & AIDS

'Undetectable' HIV patients could hold key to treatments

A rare group of HIV-positive people who maintain undetectable levels of the virus in their blood without medication could hold the key to new therapies for others living with the disease, says a leading genome expert.

HIV & AIDS

S.Africa's HIV research power couple says fight goes on

Through decades of pioneering work on fighting the spread of infectious diseases such as HIV, South African public health power couple Quarraisha and Salim Abdool Karim are credited with saving thousands of lives.

HIV & AIDS

How HIV/AIDS got its name

The Centers for Disease Control and Prevention first used the term "AIDS" on Sept. 24, 1982, more than a year after the first cases appeared in medical records. Those early years of the crisis were marked by a great deal ...

HIV & AIDS

Childhood HIV vaccination strategy shows promise in study

Research at Weill Cornell Medicine suggests that childhood immunization against HIV could one day provide protection before the risk of contracting this potentially fatal infection dramatically increases in adolescence.

HIV & AIDS

Ugandan women's autonomy key to safer sex, researchers say

Ugandan women's ability to negotiate the conditions and timing of sex, such as refusing sex and asking for condom use with their partners, is key to preventing several reproductive health outcomes, say experts from the Brown ...

HIV & AIDS

Cuba to test new AIDS vaccine on humans

Cuba's top biotech teams have successfully tested a new AIDS vaccine on mice, and are ready to soon begin human testing, a leading researcher told a biotechnology conference in Havana on Monday.

HIV & AIDS

One in four U.S. HIV patients don't stay in care, study shows

(Medical Xpress) -- Only about 75 percent of HIV/AIDS patients in the United States remain in care consistently, according to new research from the Perelman School of Medicine at the University of Pennsylvania published online ...

HIV & AIDS

New indicator diseases reveal hidden HIV

Today, heterosexuals in Europe are at particular risk of carrying HIV for so long that they remain undiagnosed until their immune system starts to fail and they become ill. An international study under the leadership of the ...

HIV & AIDS

Study finds HIV-specific CD4 cells that control viral levels

A subpopulation of the immune cells targeted by HIV may play an important role in controlling viral loads after initial infection, potentially helping to determine how quickly infection will progress. In the February 29 issue ...

HIV & AIDS

Researchers discover new HIV vaccine-related tool

(Medical Xpress) -- A new discovery involving two Simon Fraser University scientists could lead to a little known and benign bacterium becoming a vital new tool in the development of a vaccine against human immunodeficiency ...

HIV & AIDS

Two-thirds of Myanmar HIV patients untreated: MSF

International funding cuts threaten to deepen an HIV crisis in Myanmar, where tens of thousands of people are denied lifesaving treatment, an aid agency said Wednesday.

HIV & AIDS

New HIV-vaccine tested on people

Scientists from the Antwerp Institute of Tropical Medicine, Antwerp University Hospital and Antwerp University have tested a new 'therapeutic vaccine' against HIV on volunteers. The participants were so to say vaccinated ...

HIV & AIDS

S.Africa in $208 mln AIDS drug venture with Swiss Lonza

South Africa on Friday unveiled plans for a 1.6 billion rand ($208 million, 157 million euro) pharmaceutical plant, in a joint venture with Swiss biochemicals group Lonza to produce anti-AIDS drugs.

HIV & AIDS

HIV-infected youth, psychiatric symptoms and functional outcomes

A study of children and adolescents who had been infected perinatally (around the time of their birth) with human immunodeficiency virus (HIV) suggests little evidence of an association between specific antiretroviral therapy ...

HIV & AIDS

Lecture or listen: When patients waver on meds

Take your medicine, Doctor's orders. It's a simple idea that may seem especially obvious when the pills are the antiretroviral (ARV) drugs that add decades to the lives of HIV-positive patients. But despite the reality that ...

HIV & AIDS

South Africa recalls 1.35 million condoms

(AP) -- Some condoms burst. Others leaked like sieves. South Africa's leading anti-AIDS group said Tuesday that allegedly faulty condoms are among more than 1.35 million handed out at the African National Congress' 100th ...

HIV & AIDS

Protein discovery could lead to new HIV drugs

(Medical Xpress) -- A team of researchers at the Johns Hopkins Bloomberg School of Public Health recently discovered a new protein that enables HIV to destroy human cells. The finding provides scientists with a critical glimpse ...

HIV & AIDS

Business, social media to prevent babies with HIV

(AP) -- Business and social media leaders teamed up Friday to tackle the transmission of HIV from mothers to babies, saying the medicine and the money are largely in place, and with the right organizational skills they can ...